secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001493152-25-003091
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences announces 1-for-15 reverse stock split effective Jan 27, 2025
--------------------------------------------------------------------------------

- Shareholders approved reverse split at a special meeting on Jan 17, 2025; ratio range 1:10 to 1:100.
- Board set ratio at 1-for-15; outstanding shares to reduce from ~10.4M to ~692,580.
- No fractional shares; rounding up to next whole number; authorized shares remain 100M.
- Trading symbol ENVB unchanged; new CUSIP 29405E 406; adjusted trading begins Jan 27.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/0001493152-25-003091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer